Dec 16, 2024 · We are a clinical-stage pharmaceutical company focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases of huge unmet need. We are committed to developing better, safer, and more effective treatments that can have a real impact on the lives of our patients.

Find the latest Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

We are a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases. Our pipeline currently has two drug candidates, brilaroxazine (RP5063) and …

Dec 16, 2024 · Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a clinical-stage pharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases.

6 days ago · RVPH | Complete Reviva Pharmaceuticals Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas...

View Reviva Pharmaceuticals Holdings, Inc. RVPH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Get the latest Reviva Pharmaceuticals Holdings Inc (RVPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

Jan 22, 2025 · Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, …

Reviva intends to develop brilaroxazine for other neuropsychiatric indications including bipolar disorder, major depressive disorder (MDD) and attention-deficit/hyperactivity disorder (ADHD ...